Platelet inhibition with cangrelor in patients undergoing PCI Academic Article uri icon

Overview

MeSH Major

  • Acute Coronary Syndrome
  • Adenosine Monophosphate
  • Angioplasty, Balloon, Coronary
  • Platelet Aggregation Inhibitors

abstract

  • Cangrelor, when administered intravenously 30 minutes before PCI and continued for 2 hours after PCI, was not superior to an oral loading dose of 600 mg of clopidogrel, administered 30 minutes before PCI, in reducing the composite end point of death from any cause, myocardial infarction, or ischemia-driven revascularization at 48 hours. (ClinicalTrials.gov number, NCT00305162.)

publication date

  • December 10, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa0908628

PubMed ID

  • 19915221

Additional Document Info

start page

  • 2318

end page

  • 29

volume

  • 361

number

  • 24